Xenon Pharmaceuticals Inc. (XENE)
Xenon Pharmaceuticals Inc. (XENE) has reported earnings 47 times since Dec 15, 2014. The stock moves an average of ±4.28% the day after reporting, closing higher 29.8% of the time. Its largest post-earnings gain was +12.83% (Mar 01, 2021) and its largest decline was -17.46% (Nov 07, 2017). The next earnings report is predicted for 2026-11-06 (approximate).
Earnings reactions
How XENE moved on each past earnings report.
Earnings Impact
Total Earnings
47
Avg Abs. Movement
±4.28%
Positive %
29.8%
Negative %
70.2%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 06, 2026 | ☽ POST | -1.55% | open_in_new |
| May 07, 2026 | ☽ POST | +0.75% | open_in_new |
| Feb 26, 2026 | ☽ POST | -3.76% | open_in_new |
| Nov 03, 2025 | ☽ POST | -4.94% | open_in_new |
Earnings Count
47
Total earnings in dataset
Avg Abs. Movement
±4.28%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260903 | open_in_new SEC.gov |
| 4 | 20260831 | open_in_new SEC.gov |
| 144 | 20260828 | open_in_new SEC.gov |
| 144 | 20260813 | open_in_new SEC.gov |
| 4 | 20260813 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260813 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260807 | open_in_new SEC.gov |
| 10-Q | 20260806 | open_in_new SEC.gov |
| 8-K | 20260806 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260806 | open_in_new SEC.gov |
Frequently asked about XENE earnings
When does Xenon Pharmaceuticals Inc. report earnings next? expand_more
Xenon Pharmaceuticals Inc. (XENE)'s next earnings date is approximate for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does XENE stock move after earnings? expand_more
Over 47 reports, XENE has moved an average of ±4.28% the session after earnings, closing higher 29.8% of the time.
What was XENE's biggest post-earnings move? expand_more
XENE's largest post-earnings gain on record was +12.83% on Mar 01, 2021, and its largest decline was -17.46% on Nov 07, 2017.
Where can I find Xenon Pharmaceuticals Inc.'s SEC filings? expand_more
All of Xenon Pharmaceuticals Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right